Open Access

Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma

  • Authors:
    • Ya‑Wen An
    • Han‑Qing Liu
    • Zi‑Qian Zhou
    • Jian‑Chun Wang
    • Guang‑Yu Jiang
    • Zhi‑Wen Li
    • Feng Wang
    • Hong‑Tao Jin
  • View Affiliations

  • Published online on: July 17, 2020     https://doi.org/10.3892/or.2020.7695
  • Pages: 1596-1604
  • Copyright: © An et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of the present study was to explore the antitumor effects of sinoporphyrin sodium (DVDMS)‑mediated photodynamic therapy (PDT) and sonodynamic therapy (SDT) in glioma, and to reveal the underlying mechanisms. The uptake of DVDMS by U‑118 MG cells was detected by flow cytometry (FCM). A 630‑nm semiconductor laser and 1‑MHz ultrasound were used to perform PDT and SDT, respectively. Cell proliferation and apoptosis were evaluated using the Cell Counting Kit‑8 assay, FCM and Hoechst 33258 staining, respectively. Western blot analysis was used to detect protein expression and phosphorylation levels. BALB/c nude mice were used to establish a xenograft model of U‑118 MG cells. DVDMS was injected intravenously and PDT and SDT were performed 24 h later. An in vivo imaging system was used to evaluate the fluorescence of DVDMS, to measure tumor sizes, and to evaluate the therapeutic effects. The uptake of DVDMS by U‑118 MG cells was optimal after 4 h. PDT and SDT following DVDMS injection significantly inhibited the proliferation and increased apoptosis of glioma cells in vitro (P<0.05, P<0.01) respectively. In vivo, the fluorescence intensity of DVDMS was lower in the PDT and SDT groups compared with the DVDMS group, while tumor cell proliferation and weight were lower in the PDT and SDT groups than in the control group (P<0.05, P<0.01). However, there was no significant difference when laser, ultrasound or DVDMS were applied individually, compared with the control group. Hematoxylin and eosin staining suggested that both PDT and SDT induced significant apoptosis and vascular obstruction in cancer tissues. DVDMS‑mediated PDT and SDT inhibited the expression levels of proliferating cell nuclear antigen (PCNA) and Bcl‑xL, increased cleaved ‑caspase 3 levels, and decreased the protein phosphorylation of the PI3K/AKT/mTOR signaling pathway. Changes in the expression of PCNA, and Bcl‑xL and in the levels of cleaved‑caspase 3 were partly reversed by N‑acetyl‑L‑cysteine, a reactive oxygen species (ROS) scavenger. Similar results were obtained with FCM. DVDMS‑mediated PDT and SDT inhibited glioma cell proliferation and induced cell apoptosis in vitro and in vivo, potentially by increasing the generation of ROS and affecting protein expression and phosphorylation levels.
View Figures
View References

Related Articles

Journal Cover

October-2020
Volume 44 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
An YW, Liu HQ, Zhou ZQ, Wang JC, Jiang GY, Li ZW, Wang F and Jin HT: Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma. Oncol Rep 44: 1596-1604, 2020
APA
An, Y., Liu, H., Zhou, Z., Wang, J., Jiang, G., Li, Z. ... Jin, H. (2020). Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma. Oncology Reports, 44, 1596-1604. https://doi.org/10.3892/or.2020.7695
MLA
An, Y., Liu, H., Zhou, Z., Wang, J., Jiang, G., Li, Z., Wang, F., Jin, H."Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma". Oncology Reports 44.4 (2020): 1596-1604.
Chicago
An, Y., Liu, H., Zhou, Z., Wang, J., Jiang, G., Li, Z., Wang, F., Jin, H."Sinoporphyrin sodium is a promising sensitizer for photodynamic and sonodynamic therapy in glioma". Oncology Reports 44, no. 4 (2020): 1596-1604. https://doi.org/10.3892/or.2020.7695